Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
N Engl J Med
; 383(2): 109-119, 2020 07 09.
Article
in En
| MEDLINE
| ID: mdl-32640130
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligonucleotides
/
Oligonucleotides, Antisense
/
Superoxide Dismutase-1
/
Amyotrophic Lateral Sclerosis
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2020
Type:
Article